NOVO-NORDISK A/S (NY:NVO)

View All ReportsStreetInsider.com Reports on NVO

Nov 12, 2009 07:55 AM Barclays Starts NVO, SNY at Overweight, GSK, AZN at Equalweight, NVS at Underweight

Oct 28, 2009 05:43 PM Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report

Sep 30, 2009 09:34 AM Hapoalim Securities Initiates Coverage on Alkermes (ALKS) with a Hold; Two Uncertain Drivers

Sep 23, 2009 07:58 AM Novo Nordisk (NVO) Said The FDA Deferred Formal Feedback On Its Diabetes-Drug

Sep 11, 2009 10:31 AM Notable Analyst Rating Changes 9/11: AXL, INTC, TXT, SLB, LVS, AVY Upgraded; AIG, BBY, ALL, NOK, RNWK Downgraded

View All Press ReleasesCompany Press Releases on NVO

Nov 19, 2009 08:00AM Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Nov 11, 2009 07:30AM Paladin Reports Record Third Quarter 2009 Financial Results

Oct 30, 2009 09:00AM Novo Nordisk is Changing Possibilities in Hemophilia

Oct 29, 2009 04:00PM New Study Finds Significant Inconsistency With How Diabetes Quality of Care is Measured

Oct 27, 2009 06:50AM Trading Outlook for Generex Biotechnologies Corp. Issued by InvestorSoup.com

StreetInsider Reports on NVO by Category

• Analyst Ratings
• Mergers and Acquisitions
• Earnings
• Guidance
• Stock Buybacks
• Dividends
• Retail Sales
• Management Changes
• Insider Trades
• View More Categories

View All BlogsBlogs on NVO

Nov 20, 2009 06:36 AM The Complete List of Danish ADR Stocks

Nov 19, 2009 07:19 AM Oral-lyn vs. Afresa: How Generex Will Beat Mannkind

Oct 31, 2009 01:56 PM Grantham. Greenblatt See Value in 'Quality': 10 Guru Strategy Stocks

Oct 31, 2009 12:25 PM Earnings highlights: Baidu, Dreamworks, Honda, Microsoft, Target, Verizon ...

Oct 30, 2009 02:15 PM Pharma earnings recap: Mylan, Allergan, Novo-Nordisk

View All FilingsSEC Filings on NVO

Nov 17, 2009 06:19AM Form 6-K NOVO NORDISK A S For: Nov 17

Nov 9, 2009 09:33AM Form 6-K NOVO NORDISK A S For: Nov 09

Nov 9, 2009 08:37AM Form 6-K NOVO NORDISK A S For: Nov 09

Nov 4, 2009 06:38AM Form 6-K NOVO NORDISK A S For: Nov 04

Nov 3, 2009 07:00AM Form 6-K NOVO NORDISK A S For: Nov 03

Comments on recent NVO articles

Len B
on Jul 23, 2009
at 03:37 PM Victoza vs Byetta I was moved on to Byetta from insulin in 2008 for a period of 9 months. Everything was fine for 7 months and I lost 42 pounds in weight and my glucoze control was excellent. Unfortunately, after 7 months my glucoze levels increased dramatically and my weight started to increase once again and after taking Byetta for 9 months I had to go back to insulin once again and my weight has increased to a higher level than it was when I started Byetta.although my glucoze levels have once again come under control. I have today been introduced to Victoza by my diabetic consultant and I hope to be accepted to receive this new product. I believe that the more people that are able to try these new items the better and more accurate studies will become. Who knows, with us being fortunate enough to try these new products one day there will be total control for all!
Article: Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta

Brian C
on Jul 8, 2009
at 06:21 PM Victoza Vs Byetta one study, doesnt mean anything. I have been on Byetta for 3 years, my glucose control is excellent
Article: Novo Nordisk's (NVO) Victoza Returns More Promising Results Than Lilly's (LLY)/Amylin's (AMLN) Byetta

mark
on Jun 30, 2009
at 09:05 AM NVO Novartis is not NVO! You have mixed up two companies in this headline and Novo (NVO) is not the correct stock.
Article: Medarex (MEDX) Will Receive Milestone Payment from Novartis (NVO) for FDA Approval of Ilaris

Comments on NVO

No comments are currently available.

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?